Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
120.00
Ask:
200.00
Spread: 80.00 (66.667%)
Market Cap: £77.39m
SPSC Live PriceLast checked at - London Stock Exchange

Intraday Spectra (di/ S) Share Chart

Exercise of Options

18 Dec 2024 15:58

RNS Number : 6390Q
Spectra Systems Corporation
18 December 2024
 

Spectra Systems Corporation

(the "Company")

Exercise of Options

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies, and gaming security software, announces the exercise of options by an employee of Spectra.

The employee has exercised options over 13,339 shares of common stock of $0.01 each in the Company ("Shares") with an exercise price of 25p per share on 16 December 2024. The employee has elected to utilize the net cashless exercise feature and has therefore surrendered 1,339 shares to the Company. Accordingly, the employee will be issued 12,000 shares.

The shares being issued are restricted securities as defined in Rule 144 of the US Securities Act of 1933 and have been issued pursuant to an exemption from registration under Rule 701 promulgated under the US Securities Act of 1933.

Accordingly, the Company has issued and will apply for 12,000 Shares to be admitted to trading on AIM, which is expected to take place on or around 24 December 2024 ("Admission").The Company's issued share capital now comprises:

571,380 shares in the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC); and

47,669,592 shares in the unrestricted line ISIN number US84756T1060 (AIM:SPSY).

Spectra Systems has no Shares in treasury, therefore 48,240,972 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

 

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0)401 274 4700

 

Zeus (Nominated Adviser and Broker)

Chris Fielding (Director, Investment Banking)

James Bavister (Assistant Director)

Andrew de Andrade (Associate, Corporate Finance) 

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 3829 5000

 

 

 

Tel: +44 (0)20 3328 5665

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFEEFELTLIS
Date   Source Headline
22nd Feb 20199:04 amRNSDirector/PDMR Shareholding
19th Feb 201911:38 amRNSRemoval of Reg S restrictions from common stock
19th Feb 20197:00 amRNSDate of Audited Results
22nd Jan 20197:00 amRNSSensor Service Contract
11th Jan 20197:15 amRNSExercise of Options and Director/PDMR Shareholding
9th Jan 20197:00 amRNSExercise of Options and Director/PDMR Shareholding
2nd Jan 20197:00 amRNSFirst Orders for TruBrand in China
19th Dec 20184:16 pmRNSRemoval of Reg S restrictions from common stock
17th Dec 20187:00 amRNSChange of Registered Office
10th Dec 20187:44 amRNSTrading Update: Additional phosphour orders
20th Nov 20183:48 pmRNSExercise of Options
10th Oct 20182:37 pmRNSHolding(s) in Company
24th Sep 20187:00 amRNSInterim Results - Six Months End 30 June 2018
12th Sep 20189:58 amRNSRemoval of Reg S restrictions from common stock
3rd Sep 20187:00 amRNSTwo New Lottery Wins and Results Date
31st May 20184:03 pmRNSRemoval of Reg S restrictions from common stock
14th May 20187:00 amRNSG20 Central Bank begins Funding Sensor Development
24th Apr 20184:32 pmRNSPosting of Annual Report and Accounts
11th Apr 20187:00 amRNSExercise of Options
19th Mar 20187:00 amRNSPreliminary Results
1st Feb 20184:40 pmRNSSecond Price Monitoring Extn
1st Feb 20184:35 pmRNSPrice Monitoring Extension
1st Feb 20187:00 amRNSTrading Update
15th Jan 20187:00 amRNSLicensing Agreement and Supply Agreement
11th Dec 20177:00 amRNSAnnual General Meeting Postponed
10th Nov 20174:32 pmRNSHolding(s) in Company
23rd Oct 20173:44 pmRNSExercise of Options
16th Oct 20177:00 amRNSTrading Update
14th Sep 20175:34 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSInterim Results
21st Aug 20177:00 amRNSTrading Update and Interim Results Date
18th Jul 20177:00 amRNSRegulatory Approval for TruBrand Materials, China
7th Jul 20177:08 amRNSHolding(s) in Company
22nd Jun 20172:18 pmRNSPosting of Annual Report and Accounts
18th May 20173:47 pmRNSExercise of Options
5th May 20172:01 pmRNSExercise of Options
13th Apr 201711:26 amRNSExercise of Options
30th Mar 20177:00 amRNSPreliminary Results
17th Mar 20177:00 amRNSAppointment of Chief Financial Officer
23rd Jan 20177:00 amRNSAppointment of Chief Financial Officer
4th Jan 20177:00 amRNSTrading Update
5th Dec 20167:00 amRNSResignation of Chief Financial Officer
1st Dec 20167:00 amRNSAnnual General Meeting Postponed
3rd Oct 20167:00 amRNSNew Five Year Contract with G7 Central Bank
21st Sep 20165:06 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSInterim Results for 6 Months ended 30 June 2016
7th Sep 20167:00 amRNSInterim Results Pre-announcement
24th Jun 20167:00 amRNSPosting of Annual Report and Accounts
31st May 20167:00 amRNSGrant of share options
25th May 20165:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.